L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics ...
In a report released today, Olivier Nicolai from Goldman Sachs maintained a Buy rating on L’Oreal (0NZM – Research Report), with a price target ...
In a report released today, Guillaume Delmas from UBS maintained a Hold rating on L’Oreal (0NZM – Research Report), with a price target of €367.00. The company’s shares closed last Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results